The ACS GCI Pharmaceutical Roundtable gave out two distinguished awards during the 20th Annual GC&E Conference in Portland, Oregon this past June.
Peter Dunn, recently retired from Pfizer, was recognized for his years of dedicated service to the implementation of green chemistry and engineering through the Roundtable and within the global pharmaceutical industry. The Roundtable presented him with a “Green Chemistry & Engineering Impact in Industry” award.
Dunn was a founding member and former co-chair of the Roundtable where he helped initiate the research grant program, supported the growth of the Roundtable, and was one of the lead authors of the formative Green Chemistry article ‘Key green chemistry research areas—a perspective from pharmaceutical manufacturers’, which has received over 435 citations to date since it was published in in 2007. Later Dunn served on the editorial board of Green Chemistry and highlighted green chemistry research by coauthoring 13 of the Roundtable’s popular ‘Green Chemistry Articles of Interest’. Dunn held the industry’s first “green chemistry” position at Pfizer and developed an environmentally-friendly commercial process for making Viagra, among other scientific achievements.
Left to Right: John Wong, Pfizer; Juan Colberg, Pfizer; Sa V. Ho, Pfizer; John Tucker, Amgen; Pete Dunn, Barry Dillon, AstraZeneca; Daniel Richter, Pfizer.
Professor Charles Liotta, Georgia Tech, was recognized by the Roundtable for his life-long dedication to research and education. Liotta is a recognized leader in physical-organic and polymer chemistry; he is perhaps best known for his breakthrough discoveries and seminal books on phase transfer catalysis.
He has served for nine years as the Vice Provost for Research and Dean of Graduate Studies and has headed the Institute for Sustainable Technology and Development. In 2014 Liotta earned Professor Emeritus of Chemistry and Chemical Engineering at Georgia Tech. Liotta’s awards are numerous including a Presidential Green Chemistry Challenge Award with colleague Dr. Charles Eckert in 2004. More recently, Liotta earned an ACS GCI Pharmaceutical Roundtable Research Grant in 2012 and since then and has presented the research results at several invited symposia. The Roundtable presented Liotta with a Lifetime Achievement Award.
Prof. Liotta receives his award.
Left to right: Barry Dillon, AstraZeneca; John Tucker, Amgen; Charles Liotta, Georgia Tech; Mike Kopach, Eli Lilly.
“The Nexus Blog” is a sister publication of “The Nexus” newsletter. To sign up for the newsletter, please email gci@acs.org, or if you have an ACS ID, login to your email preferences and select “The Nexus” to subscribe.
To read other posts, go to Green Chemistry: The Nexus Blog home.